# RITROVA THERAPEUTICS INC. — Form D

RITROVA THERAPEUTICS INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-20. The offering totals $3.0M, of which $150K was reported sold. Industry: Other.

## Offering

- Filed: 2021-01-20
- Form: D
- Accession: 0001841262-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $150K
- Remaining: $2.9M
- Investors: 2
- Date of first sale: 2021-01-11
- Revenue range: Decline to Disclose
- SEC file number: 021-386817

## Issuer

- Name: RITROVA THERAPEUTICS INC.
- CIK: 0001841262
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 37 WASHINGTON SQUARE WEST, NEW YORK, NY, 10011
- Phone: 929-284-5678

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Cristina Maria Alberini | Director | New York, NY |
| Cristina Maria Alberini | Executive Officer | New York, NY |

## More

- [CIK 1841262 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1841262&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001841262-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.